Lyophilization Equipment and Services Market to grow by USD 2.65 billion from 2023 to 2028, North America to account for 36% of market growth | Technavio

The lyophilization equipment and services market is expected to grow by USD 2.65 billion from 2023 to 2028. In addition, the momentum of the market will progress at a CAGR of 7.92% during the forecast period, according to Technavio Research.

The market is segmented by end-user (pharmaceutical and biotechnology companies and other healthcare service providers), product (tray-style freeze dryer, manifold freeze dryer, and rotary freeze dryer), and geography (North America, Europe, Asia, and Rest of World (ROW)).

North America accounts for 36% of the growth of the global market during the forecast period. The US is one of the main countries that contributes to the lyophilization equipment and services market in North America due to the presence of various large-scale pharmaceutical and biotechnology companies. Moreover, there is a rise in the focus on the R&D of genes and other nucleic acid-based products in the US, including antisense oligonucleotides (ASOs). Hence, such factors drive the market growth in North America. This report offers an up-to-date analysis of the current market scenario, the latest trends and drivers, and the overall market environment. Read a Free PDF Sample Report

Company Profile:

ATS Automation Tooling Systems Inc., Azbil Corp., Baxter International Inc., Coriolis Pharma Research GmbH, Cryotec.Fr, GEA Group AG, HOF Sonderanlagenbau GmbH, Labconco Corp., LaboGene AS, Lyophilization Technology Inc., Maquinaria Industrial Dara SL, Martin Christ Gefriertrocknungsanlagen GmbH, MechaTech Systems Ltd., Millrock Technology Inc., OPTIMA packaging group GmbH, Shanghai Tofflon Science and Technology Co. Ltd., Thermo Fisher Scientific Inc., W. L. Gore and Associates Inc., Yamato Scientific Co. Ltd., and IMA Industria Macchine Automatiche Spa

ATS Automation Tooling Systems Inc: The company offers lyophilization equipment and services such as Lyoscan system.

•    To gain access to more company profiles available with Technavio, buy the report!

Lyophilization Equipment And Services Market: Segmentation Analysis

  • The market growth by the pharmaceutical and biotechnology companies segment is significant during the forecast period. There is an increasing use of lyophilization technology to extend the shelf life of a wide range of biological products, such as antibodies, proteins, peptides, coagulation factors, growth factors, cytokines, vaccines, nucleic acids, and antibody-drug conjugates. Hence, such factors are fuelling the growth of this segment which in turn drives the market growth during the forecast period.

Learn about the contribution of each segment summarized in concise infographics and thorough descriptions. View a Free PDF Sample Report

“Besides analyzing the current market scenario, our report examines historic data from 2017 to 2021”- Technavio

Lyophilization Equipment And Services Market: Driver & Trend:

  • The advantages of lyophilization over conventional drying drive the market growth. There has been a strong presence of lyophilization or freeze-drying in the market for over three decades to stabilize different types of chemical components. Moreover, it is increasingly being used by pharmaceutical and biotechnology sectors, due to its potential advantages over conventional drying, which comprises crystallization, filtration, and precipitation. Hence, such factors drive the market growth.
  • Technological advances in lyophilization
  • Rising demand for biobanks

Trend

  • The rise in demand for controlled nucleation in lyophilization is a primary trend in the market. A significant trend in the global market is controlled nucleation as nucleation behavior can impact the different steps in the lyophilization processes and product attributes.  In addition, the lack of control of the nucleation temperature can have an adverse effect on product uniformity and can lead to suboptimal lyophilization cycles.  Hence, such factors drive the market growth.

Strategic alliances among market players are a key trend in the tyrosine kinase inhibitors market. Identify key trends, drivers, and challenges in the market. Download a sample to gain access to this information.

Related Reports:

The stem cell banking market size is estimated to grow by USD 8.23 billion at a CAGR of 11.65% between 2023 and 2027.

The bioreactors market size is estimated to grow by USD 2.23 billion at a CAGR of 6.99% between 2023 and 2028.

What are the key data covered in this lyophilization equipment and services market report?

  • CAGR of the market during the forecast period
  • Detailed information on factors that will drive the growth of the lyophilization equipment and services market between 2023 and 2028.
  • Precise estimation of the lyophilization equipment and services market size and its contribution to the market in focus on the parent market
  • Accurate predictions about upcoming trends and changes in consumer behavior
  • Growth of the lyophilization equipment and services market across North America, Europe, Asia, and ROW
  • A thorough analysis of the market’s competitive landscape and detailed information about companies
  • Comprehensive analysis of factors that will challenge the growth of lyophilization equipment and services market players.
SourceTechnavio

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”